U.S. flag

An official website of the United States government

GTR Home > Tests > OnkoRisk Hereditary Urology Panel


Test order codeHelp: TP66

Test name


OnkoRisk Hereditary Urology Panel

Purpose of the test


This is a clinical test intended for Help: Diagnosis, Pre-symptomatic, Risk Assessment



Loading data ......

Click Indication tab for more information.

How to order


Not provided

Specimen source

Isolated DNA
Peripheral (whole) blood


Molecular Genetics
CSequence analysis of the entire coding region
Next-Generation (NGS)/Massively parallel sequencing (MPS)
  • Illumina NovaSeq

Summary of what is tested

Loading data ......

Click Methodology tab for more information.

Clinical utility


Not provided

Clinical validity


Clinical validity is dependent on individual patient clinical picture and family history of disease.


Not provided

Test services

  • Genetic counseling, Order code: TQ06, TQ07

Suggested reading

Practice guidelines

  • NICE, 2023
    UK NICE Guideline NG12, Suspected cancer: recognition and referral, 2023
  • NCCN, 2022
    NCCN Clinical Practice Guidelines in Oncology, Prostate Cancer, Version 4.2022
  • NICE, 2021
    UK NICE Guideline NG131, Prostate cancer: diagnosis and management, 2021
  • NCCN, 2011
    NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.